Lucid Diagnostics Files 8-K on Financials
Ticker: LUCD · Form: 8-K · Filed: Mar 25, 2025 · CIK: 1799011
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Lucid Diagnostics dropped an 8-K on March 24th detailing financial results and exhibits.
AI Summary
Lucid Diagnostics Inc. filed an 8-K on March 25, 2025, reporting on its results of operations and financial condition as of March 24, 2025. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located at 360 Madison Avenue, New York, NY.
Why It Matters
This 8-K filing provides crucial updates on Lucid Diagnostics' financial performance and condition, which is essential for investors to assess the company's current health and future prospects.
Risk Assessment
Risk Level: low — This filing is a standard 8-K reporting routine financial and operational information, not indicating any immediate or significant new risks.
Key Players & Entities
- Lucid Diagnostics Inc. (company) — Registrant
- March 24, 2025 (date) — Earliest event reported
- March 25, 2025 (date) — Filing date
- 360 Madison Avenue, New York, NY 10017 (address) — Principal Executive Offices
FAQ
What specific financial information is being disclosed in this 8-K filing?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this 8-K?
The earliest event reported is dated March 24, 2025.
What is the principal executive office address for Lucid Diagnostics Inc.?
The principal executive offices are located at 360 Madison Avenue, 25th Floor, New York, New York 10017.
What is the SEC file number for Lucid Diagnostics Inc.?
The SEC file number for Lucid Diagnostics Inc. is 001-40901.
What is the fiscal year end for Lucid Diagnostics Inc.?
The fiscal year end for Lucid Diagnostics Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 25, 2025 regarding Lucid Diagnostics Inc. (LUCD).